文献速递炎症性肠病胃肠动力与功能性疾病消化道肿瘤与早癌

临床实践新进展:应对挑战——管理IBD中的IBS症状

Recent advances in clinical practice: mastering the challenge-managing IBS symptoms in IBD.
PubMed 文献 · Gut · 2025-01-17

许多IBD患者炎症消退后仍有持续症状,按定义不能诊断IBS,但「IBD中的IBS」患病率是全球人群IBS患病率的五倍。本文综述IBD中IBS样症状的病理生理共同基础、诊断思路及基于证据的多模式治疗,包括经典与非经典药物、生活方式及微生物群干预。

要点

  • IBD患者炎症消退后持续症状常见,「IBD中的IBS」患病率超全球人群IBS五倍。
  • 诊断需先按主诉排除其他胃肠病,并早期考虑心理共病。
  • 治疗应基于证据且常为多模式,涵盖药物、生活方式及微生物群干预。

核心结论

  • IBD中IBS样症状与生活质量下降及医疗利用增加相关,诊断和治疗是必要的。
  • 治疗目标应适配这一相当部分IBD人群,不仅聚焦治疗炎症,还要照护患者。

研究设计与样本

  • 综述,总结当前关于IBD中IBS样症状的知识。
  • 检索范围原文未报告。

主要发现

  • 许多IBD患者尽管炎症过程已消退,仍报告持续症状。
  • 按定义不能诊断IBS,但「IBD中的IBS」患病率超越全球人群IBS患病率的五倍。
  • 存在病理生理共同基础,包括遗传易感性、环境触发因素、肠道微生物失调、肠道通透性增加、内脏高敏感及脑-肠互动参与。

关键数值与推荐

  • 炎症消退后症状持续时,应基于主诉排除其他胃肠病,并在诊断流程早期考虑任何可能的心理共病。
  • 后续治疗应基于证据且常为多模式,包括经典和非经典药物以及生活方式和微生物群方法,涵盖肠道、脑及其互动的广度。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a diagnosis of IBS cannot be made, the prevalence of 'IBS in IBD' surpasses the rate of IBS in the global population by fivefold. Because IBS-like symptoms are associated with a decreased quality of life and increased healthcare utilisation in IBD, diagnosis and treatment are necessary. In this review, we summarise the current knowledge on IBS-like symptoms in IBD. A pathophysiological common ground is present, which includes genetic susceptibility, environmental triggers, gut microbial dysbiosis, increased intestinal permeability, visceral hypersensitivity and involvement of brain-gut interaction. When symptoms persist after resolution of inflammation, other GI diseases should be excluded based on the chief complaint, considering any possible psychological co-morbidity early in the diagnostic work-up. Subsequent treatment should be initiated that is evidence-based and often multimodal, including classical and non-classical pharmacological agents as well as lifestyle and microbiota-based approaches, spanning the breadth of the gut, brain and its interaction. Treatment goals in this substantial part of the IBD population should be adapted to not only focus on treating the inflammation but taking care of the patient.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Wellens J, Sabino J, Vanuytsel T, et al. Recent advances in clinical practice: mastering the challenge-managing IBS symptoms in IBD. Gut. 2025. PMID: 39532478. doi:10.1136/gutjnl-2024-333565

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。